nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—CYP19A1—osteoporosis	0.631	1	CbGaD
Carbimazole—CYP19A1—Raloxifene—osteoporosis	0.233	1	CbGbCtD
Carbimazole—TPO—Differentiation Pathway—TNFSF11—osteoporosis	0.00206	0.0953	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—DKK1—osteoporosis	0.00187	0.0865	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—WNT1—osteoporosis	0.0018	0.0833	CbGpPWpGaD
Carbimazole—CYP19A1—Endogenous sterols—CYP27A1—osteoporosis	0.0013	0.0603	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—IL6R—osteoporosis	0.000732	0.0338	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—IGF1—osteoporosis	0.000721	0.0334	CbGpPWpGaD
Carbimazole—Stomatitis—Ibandronate—osteoporosis	0.00071	0.00619	CcSEcCtD
Carbimazole—Feeling abnormal—Calcium Acetate—osteoporosis	0.000703	0.00613	CcSEcCtD
Carbimazole—Alopecia—Etidronic acid—osteoporosis	0.000697	0.00607	CcSEcCtD
Carbimazole—Liver function test abnormal—Pamidronate—osteoporosis	0.000684	0.00596	CcSEcCtD
Carbimazole—Haemoglobin—Alendronate—osteoporosis	0.000675	0.00588	CcSEcCtD
Carbimazole—Haemorrhage—Alendronate—osteoporosis	0.000672	0.00585	CcSEcCtD
Carbimazole—Haemoglobin—Ibandronate—osteoporosis	0.000657	0.00573	CcSEcCtD
Carbimazole—Haemorrhage—Ibandronate—osteoporosis	0.000654	0.0057	CcSEcCtD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL1B—osteoporosis	0.000644	0.0298	CbGpPWpGaD
Carbimazole—Haemoglobin—Calcitriol—osteoporosis	0.000644	0.00561	CcSEcCtD
Carbimazole—Haemorrhage—Calcitriol—osteoporosis	0.00064	0.00558	CcSEcCtD
Carbimazole—Hypersensitivity—Calcium Acetate—osteoporosis	0.000629	0.00548	CcSEcCtD
Carbimazole—Angioedema—Etidronic acid—osteoporosis	0.000627	0.00546	CcSEcCtD
Carbimazole—Angiopathy—Estropipate—osteoporosis	0.000619	0.00539	CcSEcCtD
Carbimazole—Leukopenia—Etidronic acid—osteoporosis	0.000614	0.00535	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000606	0.028	CbGpPWpGaD
Carbimazole—Pruritus—Calcium Acetate—osteoporosis	0.000604	0.00526	CcSEcCtD
Carbimazole—Alopecia—Estropipate—osteoporosis	0.000603	0.00525	CcSEcCtD
Carbimazole—Angiopathy—Raloxifene—osteoporosis	0.000599	0.00522	CcSEcCtD
Carbimazole—Neutropenia—Pamidronate—osteoporosis	0.000599	0.00522	CcSEcCtD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000598	0.0277	CbGpPWpGaD
Carbimazole—Alopecia—Alendronate—osteoporosis	0.000594	0.00517	CcSEcCtD
Carbimazole—Angiopathy—Ibandronate—osteoporosis	0.000593	0.00517	CcSEcCtD
Carbimazole—Arthralgia—Etidronic acid—osteoporosis	0.000584	0.00509	CcSEcCtD
Carbimazole—CYP19A1—Ovarian Infertility Genes—ESR2—osteoporosis	0.000579	0.0268	CbGpPWpGaD
Carbimazole—Alopecia—Ibandronate—osteoporosis	0.000578	0.00504	CcSEcCtD
Carbimazole—Discomfort—Etidronic acid—osteoporosis	0.000577	0.00503	CcSEcCtD
Carbimazole—Infection—Etidronic acid—osteoporosis	0.000556	0.00485	CcSEcCtD
Carbimazole—Stomatitis—Pamidronate—osteoporosis	0.000556	0.00485	CcSEcCtD
Carbimazole—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.000556	0.00484	CcSEcCtD
Carbimazole—Pancytopenia—Zoledronate—osteoporosis	0.000555	0.00484	CcSEcCtD
Carbimazole—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.000553	0.00482	CcSEcCtD
Carbimazole—Neutropenia—Zoledronate—osteoporosis	0.000547	0.00476	CcSEcCtD
Carbimazole—Ill-defined disorder—Alendronate—osteoporosis	0.000543	0.00473	CcSEcCtD
Carbimazole—Angioedema—Estropipate—osteoporosis	0.000543	0.00473	CcSEcCtD
Carbimazole—Haemoglobin—Risedronate—osteoporosis	0.000542	0.00472	CcSEcCtD
Carbimazole—Haemorrhage—Risedronate—osteoporosis	0.000539	0.0047	CcSEcCtD
Carbimazole—Angioedema—Alendronate—osteoporosis	0.000534	0.00466	CcSEcCtD
Carbimazole—Agranulocytosis—Pamidronate—osteoporosis	0.000533	0.00464	CcSEcCtD
Carbimazole—Ill-defined disorder—Ibandronate—osteoporosis	0.000528	0.0046	CcSEcCtD
Carbimazole—Malaise—Alendronate—osteoporosis	0.000527	0.00459	CcSEcCtD
Carbimazole—Angioedema—Ibandronate—osteoporosis	0.00052	0.00453	CcSEcCtD
Carbimazole—TPO—Amino acid and derivative metabolism—PSMA5—osteoporosis	0.000516	0.0239	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—PSMA2—osteoporosis	0.000516	0.0239	CbGpPWpGaD
Carbimazole—Haemoglobin—Pamidronate—osteoporosis	0.000515	0.00449	CcSEcCtD
Carbimazole—Malaise—Ibandronate—osteoporosis	0.000513	0.00447	CcSEcCtD
Carbimazole—Haemorrhage—Pamidronate—osteoporosis	0.000512	0.00446	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.00051	0.00445	CcSEcCtD
Carbimazole—Stomatitis—Zoledronate—osteoporosis	0.000508	0.00443	CcSEcCtD
Carbimazole—Nausea—Calcium Acetate—osteoporosis	0.000507	0.00442	CcSEcCtD
Carbimazole—Myalgia—Estropipate—osteoporosis	0.000505	0.0044	CcSEcCtD
Carbimazole—Arthralgia—Estropipate—osteoporosis	0.000505	0.0044	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000502	0.00437	CcSEcCtD
Carbimazole—Angiopathy—Ethinyl Estradiol—osteoporosis	0.000502	0.00437	CcSEcCtD
Carbimazole—Myalgia—Alendronate—osteoporosis	0.000498	0.00434	CcSEcCtD
Carbimazole—Discomfort—Alendronate—osteoporosis	0.000492	0.00429	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000491	0.0227	CbGpPWpGaD
Carbimazole—Myalgia—Raloxifene—osteoporosis	0.00049	0.00427	CcSEcCtD
Carbimazole—Arthralgia—Raloxifene—osteoporosis	0.00049	0.00427	CcSEcCtD
Carbimazole—Angiopathy—Risedronate—osteoporosis	0.000489	0.00426	CcSEcCtD
Carbimazole—Alopecia—Ethinyl Estradiol—osteoporosis	0.000489	0.00426	CcSEcCtD
Carbimazole—Agranulocytosis—Zoledronate—osteoporosis	0.000487	0.00424	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000486	0.00424	CcSEcCtD
Carbimazole—Arthralgia—Ibandronate—osteoporosis	0.000485	0.00422	CcSEcCtD
Carbimazole—Myalgia—Ibandronate—osteoporosis	0.000485	0.00422	CcSEcCtD
Carbimazole—Infection—Estropipate—osteoporosis	0.000481	0.00419	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000481	0.00419	CcSEcCtD
Carbimazole—Liver function test abnormal—Estradiol—osteoporosis	0.000481	0.00419	CcSEcCtD
Carbimazole—Discomfort—Ibandronate—osteoporosis	0.000479	0.00417	CcSEcCtD
Carbimazole—Nervous system disorder—Estropipate—osteoporosis	0.000475	0.00414	CcSEcCtD
Carbimazole—Myalgia—Calcitriol—osteoporosis	0.000475	0.00413	CcSEcCtD
Carbimazole—Infection—Alendronate—osteoporosis	0.000474	0.00413	CcSEcCtD
Carbimazole—Skin disorder—Estropipate—osteoporosis	0.000471	0.0041	CcSEcCtD
Carbimazole—Discomfort—Calcitriol—osteoporosis	0.000469	0.00408	CcSEcCtD
Carbimazole—Infection—Raloxifene—osteoporosis	0.000466	0.00406	CcSEcCtD
Carbimazole—Angiopathy—Pamidronate—osteoporosis	0.000465	0.00405	CcSEcCtD
Carbimazole—Infection—Ibandronate—osteoporosis	0.000462	0.00402	CcSEcCtD
Carbimazole—Feeling abnormal—Etidronic acid—osteoporosis	0.000462	0.00402	CcSEcCtD
Carbimazole—Nervous system disorder—Raloxifene—osteoporosis	0.00046	0.00401	CcSEcCtD
Carbimazole—CYP19A1—Ovarian Infertility Genes—VDR—osteoporosis	0.00046	0.0213	CbGpPWpGaD
Carbimazole—Thrombocytopenia—Raloxifene—osteoporosis	0.00046	0.004	CcSEcCtD
Carbimazole—Skin disorder—Raloxifene—osteoporosis	0.000456	0.00397	CcSEcCtD
Carbimazole—Nervous system disorder—Ibandronate—osteoporosis	0.000456	0.00397	CcSEcCtD
Carbimazole—Alopecia—Pamidronate—osteoporosis	0.000453	0.00394	CcSEcCtD
Carbimazole—Skin disorder—Ibandronate—osteoporosis	0.000451	0.00393	CcSEcCtD
Carbimazole—Nausea—Ergocalciferol—osteoporosis	0.000448	0.0039	CcSEcCtD
Carbimazole—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.000447	0.00389	CcSEcCtD
Carbimazole—Urticaria—Etidronic acid—osteoporosis	0.000445	0.00388	CcSEcCtD
Carbimazole—Skin disorder—Calcitriol—osteoporosis	0.000442	0.00385	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000441	0.00385	CcSEcCtD
Carbimazole—Angioedema—Ethinyl Estradiol—osteoporosis	0.00044	0.00383	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000435	0.00379	CcSEcCtD
Carbimazole—Malaise—Ethinyl Estradiol—osteoporosis	0.000434	0.00378	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—TGFB1—osteoporosis	0.000433	0.02	CbGpPWpGaD
Carbimazole—Angioedema—Risedronate—osteoporosis	0.000429	0.00374	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000428	0.00373	CcSEcCtD
Carbimazole—Angiopathy—Zoledronate—osteoporosis	0.000425	0.0037	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000423	0.00369	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000414	0.00361	CcSEcCtD
Carbimazole—Ill-defined disorder—Pamidronate—osteoporosis	0.000414	0.00361	CcSEcCtD
Carbimazole—Alopecia—Zoledronate—osteoporosis	0.000414	0.0036	CcSEcCtD
Carbimazole—Hypersensitivity—Etidronic acid—osteoporosis	0.000413	0.0036	CcSEcCtD
Carbimazole—CYP19A1—Endogenous sterols—POMC—osteoporosis	0.000412	0.0191	CbGpPWpGaD
Carbimazole—Angiopathy—Conjugated Estrogens—osteoporosis	0.000409	0.00356	CcSEcCtD
Carbimazole—Angioedema—Pamidronate—osteoporosis	0.000408	0.00355	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000407	0.00355	CcSEcCtD
Carbimazole—Discomfort—Ethinyl Estradiol—osteoporosis	0.000405	0.00353	CcSEcCtD
Carbimazole—Malaise—Pamidronate—osteoporosis	0.000402	0.0035	CcSEcCtD
Carbimazole—Arthralgia—Risedronate—osteoporosis	0.000399	0.00348	CcSEcCtD
Carbimazole—Myalgia—Risedronate—osteoporosis	0.000399	0.00348	CcSEcCtD
Carbimazole—Leukopenia—Pamidronate—osteoporosis	0.000399	0.00348	CcSEcCtD
Carbimazole—Alopecia—Conjugated Estrogens—osteoporosis	0.000398	0.00347	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000397	0.00346	CcSEcCtD
Carbimazole—Pruritus—Etidronic acid—osteoporosis	0.000396	0.00345	CcSEcCtD
Carbimazole—Feeling abnormal—Alendronate—osteoporosis	0.000393	0.00343	CcSEcCtD
Carbimazole—Jaundice—Estradiol—osteoporosis	0.000392	0.00341	CcSEcCtD
Carbimazole—Infection—Ethinyl Estradiol—osteoporosis	0.00039	0.0034	CcSEcCtD
Carbimazole—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000385	0.00336	CcSEcCtD
Carbimazole—Urticaria—Estropipate—osteoporosis	0.000385	0.00335	CcSEcCtD
Carbimazole—Body temperature increased—Estropipate—osteoporosis	0.000383	0.00334	CcSEcCtD
Carbimazole—Feeling abnormal—Ibandronate—osteoporosis	0.000383	0.00334	CcSEcCtD
Carbimazole—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000382	0.00332	CcSEcCtD
Carbimazole—Infection—Risedronate—osteoporosis	0.00038	0.00331	CcSEcCtD
Carbimazole—Arthralgia—Pamidronate—osteoporosis	0.00038	0.00331	CcSEcCtD
Carbimazole—Myalgia—Pamidronate—osteoporosis	0.00038	0.00331	CcSEcCtD
Carbimazole—Urticaria—Alendronate—osteoporosis	0.000379	0.0033	CcSEcCtD
Carbimazole—Ill-defined disorder—Zoledronate—osteoporosis	0.000378	0.00329	CcSEcCtD
Carbimazole—Body temperature increased—Alendronate—osteoporosis	0.000377	0.00329	CcSEcCtD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL6—osteoporosis	0.000377	0.0174	CbGpPWpGaD
Carbimazole—Nervous system disorder—Risedronate—osteoporosis	0.000376	0.00327	CcSEcCtD
Carbimazole—Discomfort—Pamidronate—osteoporosis	0.000375	0.00327	CcSEcCtD
Carbimazole—Angioedema—Zoledronate—osteoporosis	0.000372	0.00324	CcSEcCtD
Carbimazole—Skin disorder—Risedronate—osteoporosis	0.000372	0.00324	CcSEcCtD
Carbimazole—Body temperature increased—Raloxifene—osteoporosis	0.000371	0.00323	CcSEcCtD
Carbimazole—Urticaria—Ibandronate—osteoporosis	0.000369	0.00322	CcSEcCtD
Carbimazole—Malaise—Zoledronate—osteoporosis	0.000367	0.0032	CcSEcCtD
Carbimazole—Body temperature increased—Ibandronate—osteoporosis	0.000367	0.0032	CcSEcCtD
Carbimazole—Leukopenia—Zoledronate—osteoporosis	0.000365	0.00318	CcSEcCtD
Carbimazole—Haemoglobin—Estradiol—osteoporosis	0.000363	0.00316	CcSEcCtD
Carbimazole—Infection—Pamidronate—osteoporosis	0.000362	0.00315	CcSEcCtD
Carbimazole—Urticaria—Calcitriol—osteoporosis	0.000361	0.00315	CcSEcCtD
Carbimazole—Haemorrhage—Estradiol—osteoporosis	0.000361	0.00314	CcSEcCtD
Carbimazole—Hepatitis—Estradiol—osteoporosis	0.000361	0.00314	CcSEcCtD
Carbimazole—Body temperature increased—Calcitriol—osteoporosis	0.00036	0.00313	CcSEcCtD
Carbimazole—Angioedema—Conjugated Estrogens—osteoporosis	0.000358	0.00312	CcSEcCtD
Carbimazole—Hypersensitivity—Estropipate—osteoporosis	0.000357	0.00311	CcSEcCtD
Carbimazole—Nervous system disorder—Pamidronate—osteoporosis	0.000357	0.00311	CcSEcCtD
Carbimazole—Thrombocytopenia—Pamidronate—osteoporosis	0.000356	0.00311	CcSEcCtD
Carbimazole—Rash—Etidronic acid—osteoporosis	0.000353	0.00308	CcSEcCtD
Carbimazole—Dermatitis—Etidronic acid—osteoporosis	0.000353	0.00307	CcSEcCtD
Carbimazole—Hypersensitivity—Alendronate—osteoporosis	0.000352	0.00306	CcSEcCtD
Carbimazole—Headache—Etidronic acid—osteoporosis	0.000351	0.00306	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000349	0.00304	CcSEcCtD
Carbimazole—Arthralgia—Zoledronate—osteoporosis	0.000347	0.00302	CcSEcCtD
Carbimazole—Myalgia—Zoledronate—osteoporosis	0.000347	0.00302	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000344	0.003	CcSEcCtD
Carbimazole—Pruritus—Estropipate—osteoporosis	0.000343	0.00299	CcSEcCtD
Carbimazole—Discomfort—Zoledronate—osteoporosis	0.000343	0.00299	CcSEcCtD
Carbimazole—Hypersensitivity—Ibandronate—osteoporosis	0.000342	0.00298	CcSEcCtD
Carbimazole—Pruritus—Alendronate—osteoporosis	0.000338	0.00294	CcSEcCtD
Carbimazole—Hypersensitivity—Calcitriol—osteoporosis	0.000335	0.00292	CcSEcCtD
Carbimazole—Arthralgia—Conjugated Estrogens—osteoporosis	0.000334	0.00291	CcSEcCtD
Carbimazole—Myalgia—Conjugated Estrogens—osteoporosis	0.000334	0.00291	CcSEcCtD
Carbimazole—Nausea—Etidronic acid—osteoporosis	0.000333	0.0029	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000332	0.00289	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000332	0.00289	CcSEcCtD
Carbimazole—Infection—Zoledronate—osteoporosis	0.00033	0.00288	CcSEcCtD
Carbimazole—Pruritus—Ibandronate—osteoporosis	0.000329	0.00286	CcSEcCtD
Carbimazole—Angiopathy—Estradiol—osteoporosis	0.000327	0.00285	CcSEcCtD
Carbimazole—Nervous system disorder—Zoledronate—osteoporosis	0.000326	0.00284	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—IL6—osteoporosis	0.000326	0.0151	CbGpPWpGaD
Carbimazole—Thrombocytopenia—Zoledronate—osteoporosis	0.000326	0.00284	CcSEcCtD
Carbimazole—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000324	0.00282	CcSEcCtD
Carbimazole—Skin disorder—Zoledronate—osteoporosis	0.000323	0.00281	CcSEcCtD
Carbimazole—Pruritus—Calcitriol—osteoporosis	0.000322	0.0028	CcSEcCtD
Carbimazole—Alopecia—Estradiol—osteoporosis	0.000319	0.00278	CcSEcCtD
Carbimazole—Infection—Conjugated Estrogens—osteoporosis	0.000318	0.00277	CcSEcCtD
Carbimazole—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000314	0.00274	CcSEcCtD
Carbimazole—Urticaria—Ethinyl Estradiol—osteoporosis	0.000312	0.00272	CcSEcCtD
Carbimazole—Skin disorder—Conjugated Estrogens—osteoporosis	0.000311	0.00271	CcSEcCtD
Carbimazole—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00031	0.00271	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.000309	0.0143	CbGpPWpGaD
Carbimazole—Rash—Estropipate—osteoporosis	0.000306	0.00266	CcSEcCtD
Carbimazole—Dermatitis—Estropipate—osteoporosis	0.000305	0.00266	CcSEcCtD
Carbimazole—Urticaria—Risedronate—osteoporosis	0.000304	0.00265	CcSEcCtD
Carbimazole—Headache—Estropipate—osteoporosis	0.000304	0.00264	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000303	0.00264	CcSEcCtD
Carbimazole—Body temperature increased—Risedronate—osteoporosis	0.000303	0.00264	CcSEcCtD
Carbimazole—Rash—Alendronate—osteoporosis	0.000301	0.00262	CcSEcCtD
Carbimazole—Dermatitis—Alendronate—osteoporosis	0.000301	0.00262	CcSEcCtD
Carbimazole—Feeling abnormal—Pamidronate—osteoporosis	0.0003	0.00261	CcSEcCtD
Carbimazole—Headache—Alendronate—osteoporosis	0.000299	0.00261	CcSEcCtD
Carbimazole—Rash—Raloxifene—osteoporosis	0.000296	0.00258	CcSEcCtD
Carbimazole—Dermatitis—Raloxifene—osteoporosis	0.000296	0.00258	CcSEcCtD
Carbimazole—Headache—Raloxifene—osteoporosis	0.000294	0.00256	CcSEcCtD
Carbimazole—Rash—Ibandronate—osteoporosis	0.000293	0.00255	CcSEcCtD
Carbimazole—Dermatitis—Ibandronate—osteoporosis	0.000293	0.00255	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000292	0.00254	CcSEcCtD
Carbimazole—Ill-defined disorder—Estradiol—osteoporosis	0.000291	0.00254	CcSEcCtD
Carbimazole—Headache—Ibandronate—osteoporosis	0.000291	0.00254	CcSEcCtD
Carbimazole—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000289	0.00252	CcSEcCtD
Carbimazole—Nausea—Estropipate—osteoporosis	0.000288	0.00251	CcSEcCtD
Carbimazole—Body temperature increased—Pamidronate—osteoporosis	0.000288	0.00251	CcSEcCtD
Carbimazole—Angioedema—Estradiol—osteoporosis	0.000287	0.0025	CcSEcCtD
Carbimazole—Rash—Calcitriol—osteoporosis	0.000287	0.0025	CcSEcCtD
Carbimazole—Dermatitis—Calcitriol—osteoporosis	0.000287	0.0025	CcSEcCtD
Carbimazole—Headache—Calcitriol—osteoporosis	0.000285	0.00248	CcSEcCtD
Carbimazole—Nausea—Alendronate—osteoporosis	0.000283	0.00247	CcSEcCtD
Carbimazole—Malaise—Estradiol—osteoporosis	0.000283	0.00247	CcSEcCtD
Carbimazole—Hypersensitivity—Risedronate—osteoporosis	0.000282	0.00246	CcSEcCtD
Carbimazole—Nausea—Raloxifene—osteoporosis	0.000279	0.00243	CcSEcCtD
Carbimazole—Pruritus—Ethinyl Estradiol—osteoporosis	0.000278	0.00242	CcSEcCtD
Carbimazole—Nausea—Ibandronate—osteoporosis	0.000276	0.0024	CcSEcCtD
Carbimazole—Feeling abnormal—Zoledronate—osteoporosis	0.000274	0.00239	CcSEcCtD
Carbimazole—Pruritus—Risedronate—osteoporosis	0.000271	0.00236	CcSEcCtD
Carbimazole—Nausea—Calcitriol—osteoporosis	0.00027	0.00235	CcSEcCtD
Carbimazole—Hypersensitivity—Pamidronate—osteoporosis	0.000268	0.00234	CcSEcCtD
Carbimazole—Myalgia—Estradiol—osteoporosis	0.000267	0.00233	CcSEcCtD
Carbimazole—Arthralgia—Estradiol—osteoporosis	0.000267	0.00233	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000265	0.00231	CcSEcCtD
Carbimazole—Urticaria—Zoledronate—osteoporosis	0.000264	0.0023	CcSEcCtD
Carbimazole—Discomfort—Estradiol—osteoporosis	0.000264	0.0023	CcSEcCtD
Carbimazole—Body temperature increased—Zoledronate—osteoporosis	0.000263	0.00229	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—CYP27A1—osteoporosis	0.000261	0.0121	CbGpPWpGaD
Carbimazole—Pruritus—Pamidronate—osteoporosis	0.000258	0.00224	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000257	0.0119	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PKM—osteoporosis	0.000255	0.0118	CbGpPWpGaD
Carbimazole—TPO—Metabolism—FDPS—osteoporosis	0.000255	0.0118	CbGpPWpGaD
Carbimazole—Infection—Estradiol—osteoporosis	0.000255	0.00222	CcSEcCtD
Carbimazole—Urticaria—Conjugated Estrogens—osteoporosis	0.000254	0.00222	CcSEcCtD
Carbimazole—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000253	0.00221	CcSEcCtD
Carbimazole—Nervous system disorder—Estradiol—osteoporosis	0.000251	0.00219	CcSEcCtD
Carbimazole—Skin disorder—Estradiol—osteoporosis	0.000249	0.00217	CcSEcCtD
Carbimazole—Rash—Ethinyl Estradiol—osteoporosis	0.000248	0.00216	CcSEcCtD
Carbimazole—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000247	0.00216	CcSEcCtD
Carbimazole—Headache—Ethinyl Estradiol—osteoporosis	0.000246	0.00214	CcSEcCtD
Carbimazole—Hypersensitivity—Zoledronate—osteoporosis	0.000245	0.00213	CcSEcCtD
Carbimazole—TPO—Metabolism—GPD2—osteoporosis	0.000242	0.0112	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PGLS—osteoporosis	0.000242	0.0112	CbGpPWpGaD
Carbimazole—Rash—Risedronate—osteoporosis	0.000241	0.0021	CcSEcCtD
Carbimazole—Dermatitis—Risedronate—osteoporosis	0.000241	0.0021	CcSEcCtD
Carbimazole—Headache—Risedronate—osteoporosis	0.00024	0.00209	CcSEcCtD
Carbimazole—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000236	0.00206	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	0.000235	0.0109	CbGpPWpGaD
Carbimazole—Pruritus—Zoledronate—osteoporosis	0.000235	0.00205	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000233	0.00203	CcSEcCtD
Carbimazole—Nausea—Ethinyl Estradiol—osteoporosis	0.000233	0.00203	CcSEcCtD
Carbimazole—Rash—Pamidronate—osteoporosis	0.00023	0.002	CcSEcCtD
Carbimazole—Dermatitis—Pamidronate—osteoporosis	0.000229	0.002	CcSEcCtD
Carbimazole—Headache—Pamidronate—osteoporosis	0.000228	0.00199	CcSEcCtD
Carbimazole—Nausea—Risedronate—osteoporosis	0.000227	0.00198	CcSEcCtD
Carbimazole—Pruritus—Conjugated Estrogens—osteoporosis	0.000227	0.00197	CcSEcCtD
Carbimazole—TPO—Metabolism—ATIC—osteoporosis	0.000221	0.0102	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PNP—osteoporosis	0.000221	0.0102	CbGpPWpGaD
Carbimazole—Nausea—Pamidronate—osteoporosis	0.000216	0.00188	CcSEcCtD
Carbimazole—Feeling abnormal—Estradiol—osteoporosis	0.000211	0.00184	CcSEcCtD
Carbimazole—Rash—Zoledronate—osteoporosis	0.00021	0.00183	CcSEcCtD
Carbimazole—Dermatitis—Zoledronate—osteoporosis	0.000209	0.00183	CcSEcCtD
Carbimazole—Headache—Zoledronate—osteoporosis	0.000208	0.00181	CcSEcCtD
Carbimazole—Urticaria—Estradiol—osteoporosis	0.000204	0.00177	CcSEcCtD
Carbimazole—Body temperature increased—Estradiol—osteoporosis	0.000203	0.00176	CcSEcCtD
Carbimazole—Rash—Conjugated Estrogens—osteoporosis	0.000202	0.00176	CcSEcCtD
Carbimazole—Dermatitis—Conjugated Estrogens—osteoporosis	0.000202	0.00176	CcSEcCtD
Carbimazole—Headache—Conjugated Estrogens—osteoporosis	0.000201	0.00175	CcSEcCtD
Carbimazole—Nausea—Zoledronate—osteoporosis	0.000198	0.00172	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000191	0.00885	CbGpPWpGaD
Carbimazole—Nausea—Conjugated Estrogens—osteoporosis	0.00019	0.00166	CcSEcCtD
Carbimazole—Hypersensitivity—Estradiol—osteoporosis	0.000189	0.00164	CcSEcCtD
Carbimazole—TPO—Metabolism—OXCT1—osteoporosis	0.000188	0.00869	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CA2—osteoporosis	0.000188	0.00869	CbGpPWpGaD
Carbimazole—TPO—Metabolism—MGLL—osteoporosis	0.000183	0.00847	CbGpPWpGaD
Carbimazole—Pruritus—Estradiol—osteoporosis	0.000181	0.00158	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000174	0.00807	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000165	0.00765	CbGpPWpGaD
Carbimazole—Rash—Estradiol—osteoporosis	0.000162	0.00141	CcSEcCtD
Carbimazole—Dermatitis—Estradiol—osteoporosis	0.000161	0.00141	CcSEcCtD
Carbimazole—Headache—Estradiol—osteoporosis	0.000161	0.0014	CcSEcCtD
Carbimazole—TPO—Metabolism—IDH2—osteoporosis	0.000156	0.0072	CbGpPWpGaD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000155	0.00717	CbGpPWpGaD
Carbimazole—Nausea—Estradiol—osteoporosis	0.000152	0.00133	CcSEcCtD
Carbimazole—TPO—Metabolism—CYP27A1—osteoporosis	0.000146	0.00677	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ACP5—osteoporosis	0.000142	0.00659	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TPI1—osteoporosis	0.000132	0.00612	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000129	0.00595	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000125	0.0058	CbGpPWpGaD
Carbimazole—TPO—Metabolism—P4HB—osteoporosis	0.000124	0.00576	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GAPDH—osteoporosis	0.000122	0.00565	CbGpPWpGaD
Carbimazole—TPO—Metabolism—RAP1A—osteoporosis	0.000119	0.0055	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ESR1—osteoporosis	0.000102	0.0047	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.0001	0.00463	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ENO1—osteoporosis	9.62e-05	0.00445	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—IRS1—osteoporosis	9.49e-05	0.00439	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PSMA5—osteoporosis	9.48e-05	0.00438	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PSMA2—osteoporosis	9.48e-05	0.00438	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.52e-05	0.00394	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—POMC—osteoporosis	8.23e-05	0.00381	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PKM—osteoporosis	7.77e-05	0.00359	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—FDPS—osteoporosis	7.77e-05	0.00359	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP19A1—osteoporosis	7.69e-05	0.00356	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PGLS—osteoporosis	7.36e-05	0.00341	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GPD2—osteoporosis	7.36e-05	0.00341	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PNP—osteoporosis	6.73e-05	0.00312	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ATIC—osteoporosis	6.73e-05	0.00312	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ADCY5—osteoporosis	6.28e-05	0.00291	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GPX1—osteoporosis	6.26e-05	0.0029	CbGpPWpGaD
Carbimazole—TPO—Metabolism—MTHFR—osteoporosis	5.78e-05	0.00267	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—OXCT1—osteoporosis	5.73e-05	0.00265	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CA2—osteoporosis	5.73e-05	0.00265	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MGLL—osteoporosis	5.58e-05	0.00258	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MYC—osteoporosis	5.28e-05	0.00244	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—IDH2—osteoporosis	4.74e-05	0.00219	CbGpPWpGaD
Carbimazole—TPO—Metabolism—POMC—osteoporosis	4.62e-05	0.00214	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP27A1—osteoporosis	4.46e-05	0.00206	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ACP5—osteoporosis	4.34e-05	0.00201	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.28e-05	0.00198	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TPI1—osteoporosis	4.03e-05	0.00187	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—P4HB—osteoporosis	3.79e-05	0.00175	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GAPDH—osteoporosis	3.72e-05	0.00172	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—RAP1A—osteoporosis	3.63e-05	0.00168	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.16e-05	0.00146	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ENO1—osteoporosis	2.93e-05	0.00136	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PSMA5—osteoporosis	2.89e-05	0.00134	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PSMA2—osteoporosis	2.89e-05	0.00134	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ADCY5—osteoporosis	1.91e-05	0.000886	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GPX1—osteoporosis	1.91e-05	0.000883	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MTHFR—osteoporosis	1.76e-05	0.000815	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—POMC—osteoporosis	1.41e-05	0.000652	CbGpPWpGaD
